# John Meyer, MD – FDA Inspection, Feb 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/john-meyer-md/6c1b83de-606d-4750-bd66-da15594bf1fd
Source feed: FDA_Inspections

> FDA inspection 1198209 of John Meyer, MD, February 14, 2023. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1198209
- Company Name: John Meyer, MD
- Inspection Date: 2023-02-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1043736 - 2018-03-05](https://www.keypedia.com/records/fda_inspections/john-meyer-md/f4e3c176-2659-46de-b7e0-01626529cee3)

## Related Officers

- [Kathryn Suttling](https://www.keypedia.com/people/kathryn-suttling/40a22409-8aba-4e9f-826b-0af51c1a7c0b)

Company: https://www.keypedia.com/companies/john-meyer-md/a1958096-2ba2-46d8-82fd-29e441011644

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c